Articles dans des revues avec comité de lecture (59)
  1. 12. Tarabichi, M., Antoniou, A., Le Pennec, S., Gacquer, D., De Saint Aubain, N., Ruscas-Craciun, L. I., Cielen, T., Laios, I., Larsimont, D., Andry, G., Dumont, J., Maenhaut, C., & Detours, V. (2018). Distinctive desmoplastic 3D morphology associated with BRAFV600E in papillary thyroid cancers. The Journal of clinical endocrinology and metabolism. doi:10.1210/jc.2017-02279
  2. 13. Fimereli, D., Fumagalli, D., Brown, D. N., Gacquer, D., Rothé, F., Salgado, R., Larsimont, D., Sotiriou, C., & Detours, V. (2018). Genomic hotspots but few recurrent fusion genes in breast cancer. Genes, Chromosomes and Cancer. doi:10.1002/gcc.22533
  3. 14. Suzuki, I., Gacquer, D., Van Heurck, R., Kumar, D., Wojno, M., Bilheu, A., Herpoel, A., Cheron, J., Polleux, F., Detours, V., & Vanderhaeghen, P. (2018). Human-specific NOTCH2NL genes expand cortical neurogenesis through Delta/Notch regulation. Cell, 173(6). doi:10.1016/j.cell.2018.03.067
  4. 15. Solinas, C., Garaud, S., De Silva, P., Boisson, A., Van den Eynden, G., de Wind, A., Risso, P., Rodrigues Vitória, J., Richard, F., Migliori, E., Noel, G., Duvillier, H., Ruscas-Craciun, L. I., Veys, I., Awada, A., Detours, V., Larsimont, D., Piccart-Gebhart, M., & Willard-Gallo, K. (2017). Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer. Frontiers in immunology, 8, 1412. doi:10.3389/fimmu.2017.01412
  5. 16. Saiselet, M., Pita, J. M., Augenlicht, A., Dom, G., Tarabichi, M., Fimereli, D., Dumont, J. E., Detours, V., & Maenhaut, C. (2016). miRNA expression and function in thyroid carcinomas: A comparative and critical analysis and a model for other cancers. Oncotarget, 7(32), 52475-52492. doi:10.18632/oncotarget.9655
  6. 17. Handkiewicz-Junak, D., Swierniak, M., Rusinek, D., Oczko-Wojciechowska, M., Dom, G., Maenhaut, C., Unger, K., Detours, V., Bogdanova, T., Thomas, G., Likhtarov, I., Jaksik, R., Kowalska, M., Chmielik, E., Jarzab, M., Swierniak, A., & Jarzab, B. (2016). Gene signature of the post-Chernobyl papillary thyroid cancer. European journal of nuclear medicine and molecular imaging, 43(7), 1267-1277. doi:10.1007/s00259-015-3303-3
  7. 18. Tarabichi, M., & Detours, V. (2016). A research note regarding "Variation in cancer risk among tissues can be explained by the number of stem cell divisions" [version 1; referees: 2 approved]. F1000Research, 5, 2044. doi:10.12688/F1000RESEARCH.9448.1
  8. 19. Saiselet, M., Gacquer, D., Spinette, A., Ruscas-Craciun, L. I., Decaussin-Petrucci, M., Andry, G., Detours, V., & Maenhaut, C. (2015). New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer. BMC genomics, 16(1), 828. doi:10.1186/s12864-015-2082-3
  9. 20. Fumagalli, D., Gacquer, D., Rothé, F., Lefort, A., Libert, F., Brown, D., Kheddoumi, N., Shlien, A., Konopka, T., Salgado, R., Larsimont, D., Polyak, K., Willard-Gallo, K., Desmedt, C., Piccart-Gebhart, M., Abramowicz, M., Campbell, P. J., Sotiriou, C., & Detours, V. (2015). Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome. Cell reports. doi:10.1016/j.celrep.2015.09.032
  10. 21. Tarabichi, M., Saiselet, M., Trésallet, C., Hoàng, C. T., Larsimont, D., Andry, G., Maenhaut, C., & Detours, V. (2015). Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer. British Journal of Cancer, 112(10), 1665-1674. doi:10.1038/bjc.2014.665
  11. 22. Fimereli, D., Gacquer, D., Detours, V., Fumagalli, D., Salgado, R., Rothé, F., Sotiriou, C., & Larsimont, D. (2015). No significant viral transcription detected in whole breast cancer transcriptomes. BMC cancer, 15(1), 147. doi:10.1186/s12885-015-1176-2
  12. 23. Le Pennec, S., Konopka, T., Gacquer, D., Fimereli, D., Tarabichi, M., Tomás, G., Savagner, F., Decaussin-Petrucci, M., Trésallet, C., Andry, G., Larsimont, D., Detours, V., & Maenhaut, C. (2015). Intratumor heterogeneity and clonal evolution in an aggressive PTC and matched metastases. Endocrine-related cancer. doi:10.1530/ERC-14-0351
    13. << Précédent 1 2 3 4 5 6 7 8 Suivant >>